<![CDATA[Novo Nordisk A/S - Press Releases]]><![CDATA[Novo Nordisk researchers nominated for Europe’s top innovation prize]]><![CDATA[Novo Nordisk donation aids Chinese pharmaceutical development and WHO efforts to combat neglected diseases]]><![CDATA[Novo Nordisk wins design award for NovoFine® Autocover®]]><![CDATA[TransTech Pharma, Inc. Acquires Three Programs for the Treatment of Metabolic Disorders from Novo Nordisk]]><![CDATA[Novo Nordisk licenses global rights to potential new haemostasis therapy]]><![CDATA[Discovery Health presents Diabetes: A Global Epidemic – a documentary on diabetes]]><![CDATA[Novo Nordisk celebrates first ever UN-observed World Diabetes Day]]><![CDATA[Novo Nordisk launches Changing Diabetes Barometer]]><![CDATA[Novo Nordisk celebrates 75-year commitment to diabetes research]]><![CDATA[Novo Nordisk receives approval for Levemir® in Japan]]><![CDATA[New data shows that the unique Levemir® weight benefit continues after two years]]><![CDATA[New data confirms NovoMix® 30 is associated with significantly fewer night-time and major hypoglycaemic events than biphasic human insulin (BHI)]]><![CDATA[Novo Nordisk receives approval in the EU for use of NovoRapid® in elderly people]]><![CDATA[The impact of childhood diabetes can be reduced by early diagnosis, prevention and improved control]]><![CDATA[New research shows inadequate blood sugar testing leaves millions of people with type 2 diabetes at risk of life-threatening complications]]><![CDATA[Novo Nordisk is rated supersector leader in the 2007 Dow Jones Sustainability Indexes]]><![CDATA[Novo Nordisk appoints new leaders of European and North American regions]]><![CDATA[Journalists from Argentina and Greece win Novo Nordisk Media Prize 2007]]><![CDATA[Novo Nordisk increases transparency on clinical trials and bioethics]]><![CDATA[Novo Nordisk expands manufacturing facility in Clayton]]>